Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 81,703 | 65,741 | 59,954 | 61,873 | 46,615 |
| Operating Income | -81,703 | -65,741 | -59,954 | -61,873 | -46,615 |
| Interest Expense | 1,246 | 1,231 | 0 | 0 | 888 |
| Other Income | 10,244 | 10,985 | 6,610 | 6,687 | 7,844 |
| Pre-tax Income | -72,705 | -55,987 | -53,344 | -55,186 | -39,659 |
| Net Income Continuous | -72,705 | -55,987 | -53,344 | -55,186 | -39,659 |
| Net Income | $-72,705 | $-55,987 | $-53,344 | $-55,186 | $-39,659 |
| EPS Basic Total Ops | -1.05 | -0.81 | -0.90 | -1.03 | -0.71 |
| EPS Basic Continuous Ops | -1.05 | -0.81 | -0.90 | -1.02 | -0.71 |
| EPS Diluted Total Ops | -1.05 | -0.81 | -0.90 | -1.03 | -0.71 |
| EPS Diluted Continuous Ops | -1.05 | -0.81 | -0.90 | -1.02 | -0.71 |
| EPS Diluted Before Non-Recurring Items | -1.05 | -0.81 | -0.90 | -0.99 | -0.71 |
| EBITDA(a) | $-85,275 | $-69,030 | $-62,763 | $-65,397 | $-49,763 |